Global Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the Global Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 14667 Mn in 2026 and is projected to reach USD 15940 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 5190 Mn, with Others at USD 4040 Mn.

Market Dynamics

The global companion animal healthcare market is witnessing significant growth due to the increasing demand for quality healthcare services for pets and rising pet ownership. According to a report published by Fortune Business Insights, the global companion animal healthcare market is projected to reach USD million billion by 2027, exhibiting a CAGR of 5.4% during the forecast period.

Companion animals, such as dogs, cats, and horses, are considered a part of the family by many individuals. As pet owners become more aware of the importance of their pet's health, the demand for quality healthcare services for companion animals is increasing. This is further supported by the rising trend of animal-human bonding, which is driving the growth of the global companion animal healthcare market.

One of the major factors contributing to the growth of the market is the increasing prevalence of chronic diseases among companion animals. Diseases, such as diabetes, arthritis, and cancer, are becoming increasingly common among pets, leading to a higher demand for pharmaceuticals for their treatment. The advent of advanced treatment options and drugs for these diseases is also driving the growth of the market.

Additionally, the rising disposable income of pet owners is another factor fueling the growth of the global companion animal healthcare market. As individuals become more financially capable, they are more willing to spend on their pets' healthcare needs, leading to an increase in the demand for pharmaceuticals.

The pharmaceutical segment is expected to dominate the global companion animal healthcare market during the forecast period. This is due to the high demand for medicines for the treatment of various diseases and conditions in companion animals. The increasing use of preventive medicines, such as vaccines and flea and tick control products, is also contributing to the growth of the pharmaceutical segment.

Furthermore, the increasing trend of pet insurance is also propelling the growth of the global companion animal healthcare market. With pet owners becoming more conscious of the rising cost of veterinary services, many are opting for pet insurance to cover their pets' healthcare costs, including pharmaceuticals.

In conclusion, the global companion animal healthcare market is witnessing significant growth owing to the increasing demand for quality healthcare services for pets and rising pet ownership. With the adoption of advanced treatment options and the rising trend of animal-human bonding, the market is expected to continue its growth trajectory in the coming years.